June M&A recap: Three deals, three billion-dollar stories. Written byAndrea Corona

June M&A recap: Three deals, three billion-dollar stories The science being built right now in discovery labs is what acquirers are already looking for. Written byAndrea Corona https://www.drugdiscoverynews.com/june-m-a-recap-three-deals-three-billion-dollar-stories-17401 June delivered one of the most concentrated bursts of biopharma dealmaking in years. Three acquisitions exceeding $10 billion each landed in a single week at the end of the month, capping a first half of 2026 that has already produced 33 deals worth $1 billion or more and $134 billion in total value — surpassing all of 2025 in roughly half the time.